首页> 外国专利> PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF ONE OR MORE ACTIVE PRINCIPLES AND APPLICATIONS THEREOF, SUCH AS THERAPEUTIC APPLICATIONS

PHARMACEUTICAL FORMULATIONS FOR THE SUSTAINED RELEASE OF ONE OR MORE ACTIVE PRINCIPLES AND APPLICATIONS THEREOF, SUCH AS THERAPEUTIC APPLICATIONS

机译:持续释放一种或多种活性成分的药物配方及其应用(例如治疗学应用)

摘要

A liquid pharmaceutical formulation (I) for prolonged release of active agent(s) (A) comprises a low viscosity aqueous colloidal suspension of submicron particles of water-soluble, biodegradable polymers (II) carrying hydrophobic groups, non-covalently associated with (A), where on parenteral injection (I) forms a gelled depot for prolonging the duration of (A) release to more than 24 hours. A liquid pharmaceutical formulation (I) for prolonged release of active agent(s) (A) comprises a low viscosity aqueous colloidal suspension (with water as dispersion medium) based on submicron particles (SMP's) of water-soluble, biodegradable polymers (II) carrying hydrophobic groups (HG's), non-covalently associated with (A). On parenteral injection, (I) forms a gelled depot in vivo (at least partially due to physiological proteins), controlling and prolonging the duration of (A) release to more than 24 hours. (I) is liquid under the injection conditions; at physiological temperature and/or pH; and/or in presence of physiological electrolytes at physiological concentrations and/or surfactant(s). Independent claims are included for: (1) a variant of (I) as described above, where the duration of release of (A) is not restricted but the concentration of (II) is sufficiently high to form a gelled depot in vivo in presence of protein(s) after parenteral injection; (2) novel derived products (preferably in powder or gel form), consisting of SMP's formed by non-covalent association of (II) and (A) as above and obtained from (I); and (3) methods of preparation of (I).
机译:用于延长活性剂(A)释放的液体药物制剂(I)包括低粘度的亚微米级水溶性水溶性胶体水性胶体悬浮液,该亚微米级颗粒包含与(A)非共价结合的疏水基团),经肠胃外注射(I)会形成凝胶状长效制剂,以延长(A)释放时间至24小时以上。用于延长活性剂(A)释放的液体药物制剂(I)包含基于水溶性可生物降解聚合物(II)的亚微米颗粒(SMP)的低粘度胶体水悬浮液(以水为分散介质)带有与(A)非共价结合的疏水基团(HG)。肠胃外注射时,(I)在体内形成胶凝贮库(至少部分归因于生理蛋白),从而将(A)释放的持续时间控制和延长至超过24小时。 (I)在注射条件下为液体;在生理温度和/或pH下;和/或在生理浓度和/或表面活性剂的生理电解质存在下。包括以下方面的独立权利要求:(1)如上所述的(I)的变体,其中(A)的释放持续时间不受限制,但(II)的浓度足够高,可以在存在的情况下在体内形成凝胶状贮库肠胃外注射后的蛋白质含量; (2)新颖的衍生产物(优选为粉末或凝胶形式),其由通过上述(I)和(A)的非共价结合形成的SMP组成,并由(I)获得; (3)(I)的制备方法。

著录项

  • 公开/公告号IL175768A

    专利类型

  • 公开/公告日2012-06-28

    原文格式PDF

  • 申请/专利权人 FLAMEL TECHNOLOGIES;

    申请/专利号IL20060175768

  • 发明设计人

    申请日2006-05-18

  • 分类号A61K9/14;A61K38/17;A61K38/20;A61K38/21;A61K47/48;A61K51/12;

  • 国家 IL

  • 入库时间 2022-08-21 17:24:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号